U.S. flag

An official website of the United States government

NM_000256.3(MYBPC3):c.3288del (p.Glu1096fs) AND Primary familial hypertrophic cardiomyopathy

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Oct 1, 2020
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001263510.1

Allele description [Variation Report for NM_000256.3(MYBPC3):c.3288del (p.Glu1096fs)]

NM_000256.3(MYBPC3):c.3288del (p.Glu1096fs)

Gene:
MYBPC3:myosin binding protein C3 [Gene - OMIM - HGNC]
Variant type:
Deletion
Cytogenetic location:
11p11.2
Genomic location:
Preferred name:
NM_000256.3(MYBPC3):c.3288del (p.Glu1096fs)
HGVS:
  • NC_000011.10:g.47333236del
  • NG_007667.1:g.24467del
  • LRG_386t1:c.3288del
  • LRG_386:g.24467del
  • LRG_386p1:p.Glu1096fs
  • NC_000011.9:g.47354787del
  • NC_000011.9:g.47354787delC
  • NM_000256.3:c.3288delGMANE SELECT
  • p.E1096DfsX93
  • p.Glu1096AspfsX93
Links:
dbSNP: rs727503172
NCBI 1000 Genomes Browser:
rs727503172

Condition(s)

Name:
Primary familial hypertrophic cardiomyopathy (HCM)
Synonyms:
Hereditary ventricular hypertrophy; Idiopathic hypertrophic subaortic stenosis
Identifiers:
MONDO: MONDO:0024573; MeSH: D024741; MedGen: C0949658; OMIM: PS192600

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000696328Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Pathogenic
(Oct 1, 2020)
germlineclinical testing

PubMed (9)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Two cases of severe neonatal hypertrophic cardiomyopathy caused by compound heterozygous mutations in the MYBPC3 gene.

Lekanne Deprez RH, Muurling-Vlietman JJ, Hruda J, Baars MJ, Wijnaendts LC, Stolte-Dijkstra I, Alders M, van Hagen JM.

J Med Genet. 2006 Oct;43(10):829-32. Epub 2006 May 5.

PubMed [citation]
PMID:
16679492
PMCID:
PMC2563166

Mutations in sarcomeric protein genes not only lead to cardiomyopathy but also to congenital cardiovascular malformations.

Wessels MW, Willems PJ.

Clin Genet. 2008 Jul;74(1):16-9. doi: 10.1111/j.1399-0004.2008.00985.x. Epub 2008 Apr 8.

PubMed [citation]
PMID:
18400036
See all PubMed Citations (9)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV000696328.2

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (9)

Description

Variant summary: MYBPC3 c.3288delG (p.Glu1096AspfsX93) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory. The variant was absent in 210992 control chromosomes. c.3288delG has been reported in the literature in multiple individuals affected with Hypertrophic Cardiomyopathy (examples- Lekanne_2006, Waldmuller_2011, Kapplinger_2014, Bos_2014, Walsh_2017, van Lint_2019). These data indicate that the variant is very likely to be associated with disease, however at least one publication reports the variant in an unaffected individual, suggesting imcomplete penetrance (Lekanne_2006). One publication reports that mRNA with the variant could not be detected in the peripheral blood of a patient with this mutation, indicating nonsense-mediated decay (Lekanne_2006). Six other clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation, citing the variant as pathogenic (n=5) and uncertain significance (n=1). Based on the evidence outlined above, the variant was classified as pathogenic.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: May 1, 2024